Life Science Company News

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Invitae Enters into Agreement with Labcorp for Sale of Business

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Labcorp Announces Winning Bid for Select Assets of Invitae

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Nutriessential expands globally to Oceania, Asia and the Gulf

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Genomma Lab Internacional Announces Results for the First Quarter 2024

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Cytokinetics to Announce First Quarter Results on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Madrigal Statement on the Passing of Dr. Stephen Harrison

Read more ››
By: GlobeNewswire - 24 Apr 2024

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

Read more ››
By: GlobeNewswire - 24 Apr 2024

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more ››
By: GlobeNewswire - 24 Apr 2024

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Onco

Read more ››
By: GlobeNewswire - 24 Apr 2024

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

Read more ››
By: GlobeNewswire - 24 Apr 2024

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Read more ››
By: GlobeNewswire - 24 Apr 2024

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing

Read more ››
By: GlobeNewswire - 24 Apr 2024

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate